Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial

Ji Yoon Kim,Sang-Man Jin,Eun Seok Kang,Soo Heon Kwak,Yeoree Yang,Jee Hee Yoo,Jae Hyun Bae,Jun Sung Moon,Chang Hee Jung,Ji Cheol Bae,Sunghwan Suh,Sun Joon Moon,Sun Ok Song,Suk Chon,Jae Hyeon Kim

Diabetologia（2024）

引用 0|浏览3

暂无评分

摘要

This study compares the efficacy and safety of a tubeless, on-body automated insulin delivery (AID) system with that of a tubeless, on-body sensor-augmented pump (SAP). This multicentre, parallel-group, RCT was conducted at 13 tertiary medical centres in South Korea. Adults aged 19–69 years with type 1 diabetes who had HbA1c levels of <85.8 mmol/mol (<10.0

查看译文

关键词

Artificial pancreas,Automated insulin delivery,Hybrid closed-loop,On-body automated insulin delivery system,Sensor-augmented pump,Tubeless patch pump,Type 1 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要